医院手术量对周围动脉疾病血管内治疗远期结局的影响
基于日本2014年4月至2020年3月住院数据库,纳入127486例下肢周围动脉疾病接受血管内治疗的患者,按年医院手术量四分位分组,评估12个月截肢、全因死亡、复合结局和再入院;发现手术量最高组全因死亡和复合结局显著降低,但截肢率无显著差异,再入院略升高,住院时长存在正向关联,总费用无显著差异。
要点
- 年手术量最高组(68-289例)与最低组(1-27例)相比,12个月全因死亡OR 0.71(95%CI 0.65-0.76)。
- 各手术量分位组12个月截肢率无显著差异,最高组OR 1.00(95%CI 0.93-1.07)。
- 最高手术量组复合结局OR 0.84(95%CI 0.80-0.89),再入院OR 1.05(95%CI 1.02-1.09)。
核心结论
- 年医院血管内治疗手术量与下肢周围动脉疾病患者12个月截肢率无显著关联,但最高手术量组全因死亡和复合结局显著降低。
研究设计与样本
- 基于日本诊断程序组合住院数据库2014年4月至2020年3月数据,链接医疗机构调查数据,识别接受经皮腔内血管成形和血栓清除术或经皮血管内取出术的患者,共纳入127486例,按年医院手术量四分位分组:第一分位1-27例(31579例)、第二分位28-44例(31913例)、第三分位45-67例(31999例)、第四分位68-289例(31995例),采用广义线性模型分析12个月截肢、全因死亡、复合结局和再入院。
主要发现
- 与第一分位相比,第二分位12个月截肢OR 0.97(95%CI 0.90-1.04),第三分位OR 1.00(95%CI 0.93-1.07),第四分位OR 1.00(95%CI 0.93-1.07),均无显著差异。
- 第四分位与第一分位相比,12个月全因死亡OR 0.71(95%CI 0.65-0.76),复合结局OR 0.84(95%CI 0.80-0.89),再入院OR 1.05(95%CI 1.02-1.09),差异显著。
- 第一分位与其他分位在住院时长上存在正向关联,各分位间总医疗费用无显著差异。
局限性
- 原文结论指出需要进一步研究,包括对术者手术量和操作特征的探讨,以明确医院手术量与远期不良结局之间的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the association between annual hospital volume of endovascular therapy (EVT) and long-term outcomes in patients with lower-extremity peripheral artery disease (PAD). MATERIALS AND METHODS: We identified patients who underwent percutaneous endovascular transluminal angioplasty and thrombectomy of the extremities or percutaneous endovascular removal in the Japanese Diagnosis Procedure Combination inpatient database from April 2014 to March 2020 linked to the Survey of Medical Institutions data. A generalized linear model analysis was performed to assess 12-month amputation, all-cause death, composite outcome (amputation and death), and readmission. We also analyzed length of hospital stay and total health care costs during the first hospitalization. RESULTS: Among 127 486 eligible patients, 31 579, 31 913, 31 999, and 31 995 were in the first (1-27 cases/year), second (28-44 cases), third (45-67 cases), and fourth (68-289 cases) quartiles, respectively. There were no significant differences in 12-month amputation among the second (odds ratio [OR], 0.97; 95% confidence interval [CI], 0.90-1.04), third (OR, 1.00; 95% CI, 0.93-1.07), and fourth (OR, 1.00; 95% CI, 0.93-1.07) quartile volumes compared with the first quartile. Significant differences were observed in 12-month death (OR for fourth quartile with reference to the first quartile, 0.71; 95% CI, 0.65-0.76), composite outcome (OR, 0.84; 95% CI, 0.80-0.89), and readmission (OR, 1.05; 95% CI, 1.02-1.09). CONCLUSIONS: We found that the annual hospital volume of EVT was not associated with decreased 12-month amputation in patients with lower-extremity PAD. In contrast, all-cause death and composite outcome were significantly decreased in hospitals with the highest volume.Clinical ImpactThe association between hospital volume of endovascular therapy and long-term adverse clinical outcomes remains unclear. The present analyses showed no significant differences in 12-month amputation rates among the hospital volumes, whereas higher-volume quartiles were significantly associated with decreased 12-month all-cause death rates and composite outcome. There was also a positive association in the length of stay between the first quartile volume and the others, while no significant difference in total health care costs among the quartiles was observed. Further investigations are needed, including insights into operator volume and procedural characteristics, to clarify the relationship between hospital volume and long-term adverse outcomes.
引用
- Setogawa N, Ohbe H, Matsui H, et al. Impact of Hospital Volume on Long-Term Outcomes After Endovascular Therapy for Peripheral Artery Disease. J Endovasc Ther. 2023. PMID: 37675778. doi:10.1177/15266028231198206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。